Esperion Therapeutics
ESPR
#6169
Rank
S$1.14 B
Marketcap
S$4.83
Share price
-1.58%
Change (1 day)
8.12%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): S-$0.71

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is S-$0.70. In 2024 the company made an earnings per share (EPS) of S-$0.30 an increase over its 2023 EPS that were of S-$2.75.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.71139.64%
2024S-$0.30-89.15%
2023S-$2.75-40.28%
2022S-$4.60-62.87%
2021S-$12.3980.38%
2020S-$6.8750.14%
2019S-$4.57-53.18%
2018S-$9.777.41%
2017S-$9.10110.81%
2016S-$4.3247.35%
2015S-$2.930.89%
2014S-$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
S-$7.70 1,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$3.52-603.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.23-418.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$56.29-8,144.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14-79.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S-$0.25-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA